The global liver fibrosis treatment market is projected to grow significantly, with revenues rising from USD 17.51 billion in 2024 to USD 51.16 billion by 2033, marking a robust compound annual growth rate (CAGR) of 10.8% throughout the forecast period 2025-233.
Interventional cardiology devices market was valued at US$ 16.89 billion in 2024 and is projected to hit the market valuation of US$ 30.23 billion by 2033 at a CAGR of 7.55% during the forecast period 2025–2033.
Europe medical devices market was valued at US$ 193.9 billion in 2024 and is projected to hit the valuation of US$ 305.01 billion by 2033 at a CAGR of 5.0% during the forecast period 2025-2033.
The U.S. medical devices market was valued at US$ 184.5 billion in 2024 and is projected to hit the valuation of US$ 311.50 billion by 2033 at a CAGR of 5.8% during the forecast period 2025-2033.
Veterinary lasers market was valued at US$ 310.12 million in 2024 and is projected to hit the market valuation of US$ 727.36 million by 2033 at a CAGR of 9.1% during the forecast period 2025–2033.
Bronchial biopsy devices market was valued at US$ 681.2 million in 2024 and is projected to hit the market valuation of US$ 1,350.4 million by 2033 at a CAGR of 7.9% during the forecast period 2025–2033.
Argentina diabetes devices market was valued at US$ 539.12 million in 2024 and is projected to hit the market valuation of US$ 1,031.89 million by 2033 at a CAGR of 7.48% during the forecast period 2025–2033.